From 2013 to 2023, the dosage market for Penicillins and Streptomycins in Moldova displayed a fluctuating trend. By 2023, the market size stood at $2.19 per capita, marking a significant decrease from previous years.
In the past two years (2022-2023), a year-on-year decrease was observed in the market size. Over a five-year period (2019-2023), the market experienced a compound annual growth rate (CAGR) decline, reflecting a consistent downward trend.
Looking ahead, key trends to monitor include potential market stabilization strategies, shifts in healthcare policy, antibiotic resistance challenges, and the impact of generic drug competition. Innovations in healthcare and economic factors will also influence future market developments.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 21 | 21 Guatemala | 2.36 | 2023 | View data | ||
| 22 | 22 South Africa | 2.34 | 2023 | View data | ||
| 23 | 23 Moldova | 2.19 | 2023 | |||
| 24 | 24 Brazil | 2.01 | 2023 | View data | ||
| 25 | 25 Malaysia | 1.87 | 2023 | View data | ||
